Inhibition by fluoxetine of cytochrome P450 2D6 activity

@article{Otton1993InhibitionBF,
  title={Inhibition by fluoxetine of cytochrome P450 2D6 activity},
  author={S. Otton and D. Wu and R. Joffe and S. Cheung and E. Sellers},
  journal={Clinical Pharmacology & Therapeutics},
  year={1993},
  volume={53}
}
Potent inhibition of cytochrome P450 2D6 (CYP2D6) in human liver microsomes by fluoxetine and its major metabolite norfluoxetine was confirmed (apparent inhibition constant values, 0.2 μmol/L). Several other serotonergic agents were also found to be competitive inhibitors of this genetically polymorphic enzyme. The O‐demethylation ratio of dextromethorphan that expressed CYP2D6 activity in 19 patients receiving fluoxetine fell in the region of the antimode separating the O‐demethylation ratio… Expand
251 Citations
Human cytochromes mediating N-demethylation of fluoxetine in vitro
  • 72
Antidepressant Drug Interactions and the Cytochrome P450 System
  • 136
Venlafaxine oxidation in vitro is catalysed by CYP2D6.
  • 208
Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
  • 222
  • PDF
Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity
  • 105
  • Highly Influenced
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 63 REFERENCES
Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine
  • 13
Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype
  • 151
The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.
  • 391
Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype.
  • 155
...
1
2
3
4
5
...